Novel agents that downregulate EGFR, HER2, and HER3 in parallel

Item

http://www.wikidata.org/entity/Q35833034

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Novel agents that downregulate EGFR, HER2, and HER3 in parallel

@ast

Novel agents that downregulate EGFR, HER2, and HER3 in parallel

@en

type

Item

label

Novel agents that downregulate EGFR, HER2, and HER3 in parallel

@ast

Novel agents that downregulate EGFR, HER2, and HER3 in parallel

@en

prefLabel

Novel agents that downregulate EGFR, HER2, and HER3 in parallel

@ast

Novel agents that downregulate EGFR, HER2, and HER3 in parallel

@en

P1476

Novel agents that downregulate EGFR, HER2, and HER3 in parallel

@en

P2093

Bradley John Davis

http://www.w3.org/2001/XMLSchema#string

Brian Keith Law

http://www.w3.org/2001/XMLSchema#string

Mary Elizabeth Law

http://www.w3.org/2001/XMLSchema#string

Mary Reinhard

http://www.w3.org/2001/XMLSchema#string

Stephan Christopher Jahn

http://www.w3.org/2001/XMLSchema#string

P2860

Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains

Rapamycin potentiates transforming growth factor beta-induced growth arrest in nontransformed, oncogene-transformed, and human cancer cells.

Cell signaling by receptor tyrosine kinases

Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants

Structure of the extracellular region of HER3 reveals an interdomain tether

Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab

The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.

Inhibition of multiple phases of human immunodeficiency virus type 1 replication by a dithiane compound that attacks the conserved zinc fingers of retroviral nucleocapsid proteins

P304

10445-10459

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.3398

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ronald K Castellano

Renan B Ferreira

C Heldermon

P577

2015-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274901752

http://www.w3.org/2001/XMLSchema#string

P698

25865227

http://www.w3.org/2001/XMLSchema#string

P932

4496366

http://www.w3.org/2001/XMLSchema#string